Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

NCT00813124 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Stem Cell Transplantation
Leukemia

Interventions

DRUG: Fludarabine
DRUG: Busulfan
DRUG: Thymoglobulin
DRUG: Azacitidine
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]